South & Central America Helicobacter Pylori (H. pylori) Non-invasive Testing Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Test Type (Serology, Stool Antigen, and Urea Breath), Test Method (Laboratory Based and Point-of-Care), and End User (Hospitals, Clinics, and Diagnostic Laboratories)

Code: BMIRE00027546 | Pages: 114 | Industry: Medical Device | Date: Nov 2022 | Type: Regional

The helicobacter pylori (H. pylori) non-invasive testing market in South & Central America is expected to grow from US$ 26.14 million in 2022 to US$ 34.64 million by 2028; it is estimated to grow at a CAGR of 4.8% from 2022 to 2028.       

 

Introduction of Artificial Intelligence to Provide Opportunities to South & Central America Helicobacter

Pylori (H. pylori) Non-invasive Testing Market Players

 

The advancement in the field of computer technologies has led to the introduction of artificial intelligence technologies, which have been utilized to enhance the diagnosis and predict disease progression and treatment planning. Several studies have shown the capability of artificial intelligence in predicting H. pylori status for diagnosing gastritis. In 2019, Cancer Informatics and Inspirata entered into a technical partnership with DeePathology to grant joint customers the ability to utilize the DeePathology H. pylori decision support system, a screening tool, directly from Dynamyx, a digital pathology solution by Inspirata. The product can enhance reporting accuracy and safely accelerate the H. Pylori diagnostic process. Thus, the emergence of artificial intelligence will offer new opportunities for pharmaceutical companies, which is expected to provide growth opportunities to the helicobacter pylori (H. pylori) non-invasive testing market.

 

Market Overview

 

The number of cancer cases in Argentina is increasing at a steady rate. According to WHO, in 2020, ~130,878 new cases of cancer were diagnosed, of which 22,024 were breast cancer, while 15,605 were colorectal cancer and others. Further, ~70,000 deaths are caused by cancer per year, which is the third-highest cancer mortality rate in Latin America. Breast cancer is the most common type, with 73 cases per 100,000 women each year. Moreover, according to OECD, the healthcare expenditure in Argentina has increased. The surge is due to a growing need for health systems, infrastructure, human resources, diagnostics, treatment, and financing owing to the rising number of diseases and infections across the country. These factors are expected to provide significant growth opportunities to the (H. pylori) non-invasive testing market players during the forecast period.

 

South & Central America Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecast to 2028 (US$ Million)

South & Central America Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecast to 2028 (US$ Million)

Get more information on this report :

 

 

South & Central America Helicobacter Pylori (H. pylori) Non-invasive Testing Market Segmentation

 

The South & Central America helicobacter pylori (H. pylori) non-invasive testing market is segmented on test type, test method, end user, and country.

  • Based on test type, the South & Central America Helicobacter pylori (H. pylori) non-invasive testing market is segmented into serology, stool antigen, and urea breathe. In 2022, the urea breath segment is expected to hold the largest share of the market.
  • Based on test method, the South & Central America Helicobacter pylori (H. pylori) non-invasive testing market is bifurcated into laboratory based and point of care. The laboratory based segment is expected to hold a larger share of the market in 2022.
  • Based on end user, the South & Central America Helicobacter pylori (H. pylori) non-invasive testing market is segmented into hospitals, clinics, and diagnostic laboratories. The diagnostic laboratories segment is expected to hold the largest share of the market in 2022. 
  • Based on country, the South & Central America Helicobacter pylori (H. pylori) non-invasive testing market is segmented into Brazil, Argentina, and the Rest of South & Central America. Further, Brazil is expected to hold the largest share of the market in 2022.    

Abbott Laboratories; Bio-Rad Laboratories Inc.; CerTest Biotec; Coris BioConcept; DiaSorin S.p.A.; Meridian Bioscience Inc.; QuidelOrtho Corporation; Sekisui Diagnostics; Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd; and Thermo Fisher Scientific Inc. are the leading companies operating in the helicobacter pylori (H. pylori) non-invasive testing market in South & Central America.   

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        SAM Helicobacter Pylori (H. pylori) Non-invasive Testing Market – By Test Type

1.3.2        SAM Helicobacter Pylori (H. pylori) Non-invasive Testing Market – By Test Method

1.3.3        SAM Helicobacter Pylori (H. pylori) Non-invasive Testing Market – By End User

1.3.4        SAM Helicobacter Pylori (H. pylori) Non-invasive Testing Market – By Country

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           SAM Helicobacter Pylori (H. pylori) Non-invasive Testing Market – Market Landscape

4.1         Overview

4.2         SAM PEST Analysis

4.3         Experts Opinion

5.           SAM Helicobacter Pylori (H. pylori ) Non-Invasive Testing Market – Key Industry Dynamics

5.1         Key Market Drivers

5.1.1        Increasing prevalence of H. pylori bacterial infection

5.1.2        New Product Launches & FDA Approvals for Noninvasive Tests

5.1.3        Spreading Awareness Among Individuals Regarding Diagnosis of H. pylori

5.1.4        Rise in Investments by Pharmaceutical Companies

5.2         Key Market Restraints

5.2.1        Low Diagnosis Rate

5.3         Key Market Opportunities

5.3.1        Increasing Number of Conferences and Events for Research

5.3.2        Introduction of Artificial Intelligence

5.4         Future Trends

5.4.1        Increasing Use of Home-Based POC Devices

5.4.2        Diagnosis for Resistance

5.5         Impact Analysis

6.           Helicobacter pylori (H. pylori) Non-Invasive Testing Market– SAM Analysis

6.1         SAM Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue Forecast and Analysis

7.           SAM Helicobacter pylori (H. pylori) Non-Invasive Testing Market Analysis– by Test Type

7.1         Overview

7.2         SAM Helicobacter pylori (H. pylori) Non-invasive Testing Market, By Test Type 2022 & 2028 (%)

7.3         Serology Test

7.3.1        Overview

7.3.2        SAM Serology Test Market Revenue and Forecasts to 2028 (US$ Mn)

7.4         Stool Antigen Test

7.4.1        Overview

7.4.2        SAM Stool Antigen Test Market Revenue and Forecasts to 2028 (US$ Mn)

7.5         Urea Breath Test

7.5.1        Overview

8.           SAM Helicobacter pylori (H. pylori) Non-Invasive Testing Market Analysis– by Test Method

8.1         Overview

8.2         SAM Helicobacter pylori (H. pylori) Non-invasive Testing Market, By Test Method 2022 & 2028 (%)

8.3         Laboratory Based Tests

8.3.1        Overview

8.3.2        SAM Laboratory Based Tests Market Revenue and Forecasts to 2028 (US$ Mn)

8.4         Point Of Care Tests

8.4.1        Overview

8.4.2        SAM Point of Care Tests Market Revenue and Forecasts to 2028 (US$ Mn)

9.           SAM Helicobacter pylori (H. pylori) Non-invasive Testing Market Analysis– by End User

9.1         Overview

9.2         SAM Helicobacter pylori (H. pylori) Non-invasive Testing Market, By End User 2018 & 2028 (%)

9.3         Hospitals

9.3.1        Overview

9.3.2        SAM Hospitals Market Revenue and Forecasts to 2028 (US$ Mn)

9.4         Clinics

9.4.1        Overview

9.4.2        SAM Clinics Market Revenue and Forecasts to 2028 (US$ Mn)

9.5         Diagnostic Laboratories

9.5.1        Overview

9.5.2        SAM Diagnostic Laboratories Market Revenue and Forecasts to 2028 (US$ Mn)

10.        SAM Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts to 2028 – Country Analysis

10.1      Overview

10.1.1     SAM Helicobacter pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts to 2028, By Country (%)

10.1.1.1       Argentina Helicobacter pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.1.1       Argentina Helicobacter pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.1.2       Argentina Helicobacter pylori (H. pylori) Non-invasive Testing Market Revenue And Forecasts to 2028, By Test (US$ Mn)

10.1.1.1.3       Argentina Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue And Forecasts To 2028, By Test Method (US$ MN)

10.1.1.1.4       Argentina Helicobacter pylori (H. pylori) Noninvasive Testing Market Revenue And Forecasts to 2028, By End User (US$ Mn)

10.1.1.2       Brazil Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.2.1       Brazil Helicobacter pylori (H. pylori) Noninvasive Testing Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.2.2       Brazil Helicobacter pylori (H. pylori) Noninvasive Testing Market Revenue and Forecasts to 2028, By Test (US$ Mn)

10.1.1.2.3       Brazil Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts To 2028, By Test Method (US$ MN)

10.1.1.2.4       Brazil Helicobacter pylori (H. pylori) Noninvasive Testing Market Revenue and Forecasts to 2028, By End User (US$ Mn)

10.1.1.3       Rest of SAM Helicobacter pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.3.1       Rest of SAM Helicobacter pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.3.2       Rest of SAM Helicobacter pylori (H. pylori) Non-invasive Testing Market Revenue And Forecasts to 2028, By Test (US$ Mn)

10.1.1.3.3       Rest of SAM Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue And Forecasts To 2028, By Test Method (US$ MN)

10.1.1.3.4       Rest of SAM Helicobacter pylori (H. pylori) Non-invasive Testing Market Revenue And Forecasts to 2028, By End User (US$ Mn)

11.        Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market–Industry Landscape

11.1      Overview

11.2      Growth Strategies in the Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market

11.3      Inorganic Growth Strategies

11.3.1     Overview

11.4      Organic Growth Strategies

11.4.1     Overview

12.        Company Profile

12.1      DiaSorin S.p.A.

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      Meridian Bioscience, Inc.

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      QuidelOrtho Corporation

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      Abbott Laboratories

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Thermo Fisher Scientific Inc.

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      CerTest Biotec

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      Sekisui Diagnostics

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      Coris BioConcept

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9      Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd.

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Products and Services

12.9.4     Financial Overview

12.9.5     SWOT Analysis

12.9.6     Key Developments

12.10   Bio-Rad Laboratories, Inc.

12.10.1  Key Facts

12.10.2  Business Description

12.10.3  Products and Services

12.10.4  Financial Overview

12.10.5  SWOT Analysis

12.10.6  Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

 

 

LIST OF TABLES

Table 1.             Argentina Helicobacter pylori (H. pylori) Noninvasive Testing Market Revenue And Forecasts to 2028, By Test (US$ Mn)

Table 2.             Argentina Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market, by Test Method – Revenue and Forecast to 2028 (USD Million)

Table 3.             Argentina Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 4.             Brazil Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market, by Test Type – Revenue and Forecast to 2028 (USD Million)

Table 5.             Brazil Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market, by Test Method – Revenue and Forecast to 2028 (USD Million)

Table 6.             Brazil Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 7.             Rest of SAM Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market, by Test Type – Revenue and Forecast to 2028 (USD Million)

Table 8.             Rest of SAM Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market, by Test Method – Revenue and Forecast to 2028 (USD Million)

Table 9.             Rest of SAM Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 10.          Recent Inorganic Growth Strategies in the Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market

Table 11.          Recent Organic Growth Strategies in the Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market

Table 12.          Glossary of Terms

 

LIST OF FIGURES

Figure 1.           SAM Helicobacter Pylori (H. pylori ) Non-invasive Testing Market Segmentation

Figure 2.           SAM Helicobacter Pylori (H. pylori ) Non-invasive Testing Market, By Country

Figure 3.           SAM Helicobacter Pylori (H. pylori) Non-invasive Testing Market Overview

Figure 4.           Urea Breath Segment Held Largest Share of Test Type Segment in SAM Helicobacter Pylori (H. pylori) Non-invasive Testing Market

Figure 5.           Argentina is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           SAM: PEST Analysis

Figure 7.           Experts Opinion

Figure 8.           SAM Helicobacter pylori Non-Invasive Testing Market Impact Analysis of Driver and Restraints

Figure 9.           SAM Helicobacter pylori (H. pylori) Non-Invasive Testing Market– Revenue Forecast and Analysis – 2020 - 2028

Figure 10.        SAM Helicobacter pylori (H. pylori) Noninvasive Testing Market, by Test Type 2022 & 2028 (%)

Figure 11.        SAM Serology Test Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 12.        SAM Stool Antigen Test Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 13.        SAM Urea Breath Test Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 14.        SAM Helicobacter pylori (H. pylori) Noninvasive Testing Market, by Test Method 2022 & 2028 (%)

Figure 15.        SAM Laboratory Based Tests Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 16.        SAM Point Of Care Tests Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 17.        SAM Helicobacter pylori (H. pylori) Noninvasive Testing Market, by End User 2018 & 2028 (%)

Figure 18.        SAM Hospitals Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 19.        SAM Clinics Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 20.        SAM Diagnostic Laboratories Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 21.        SAM Helicobacter Pylori (H. pylori) Noninvasive Testing Market Revenue Overview, by Country, 2022 (US$ Mn)

Figure 22.        SAM Helicobacter pylori (H. pylori) Noninvasive Testing Market Revenue and Forecasts to 2028, By Country (%)

Figure 23.        Argentina Helicobacter pylori (H. pylori) Noninvasive Testing Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 24.        Brazil Helicobacter pylori (H. pylori) Noninvasive Testing Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 25.        Rest of SAM Helicobacter pylori (H. pylori) Noninvasive Testing Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 26.        Growth Strategies in the Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market

  1. Abbott Laboratories
  2. Bio-Rad Laboratories Inc.
  3. CerTest Biotec; Coris BioConcept
  4. Coris BioConcept
  5. DiaSorin S.p.A.
  6. Meridian Bioscience Inc.
  7. QuidelOrtho Corporation
  8. Sekisui Diagnostics
  9. Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd
  10. Thermo Fisher Scientific Inc.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
Site License
$4000
Enterprise License
$5000